ARCHIVES

Cancer Groups Urge FDA To Spell Out Standards For Data Collection In Time-To-Progression Trials.

This article is from The Cancer Letter archive.

Vol. 34 No. 41 | November 7, 2008

Download PDF Visit The Full Archive

Related Articles

Three Cancer Centers Test Targeted Therapy For Resistant Acute Myelogenous Leukemia

July 26, 2002

In Brief: Rhoads, Schmidt Bow Out – Amos, Krim Possible Replacements; Sibal acting Virology Director

January 27, 1978

C. Gordon Zubrod, 84, Dies, Led Chemotherapy Research, Built Cooperative Group System

January 29, 1999

In Brief: Congress Finished Spending Bill, Reagan Signs It; NCI Gets $1.402 Billion, a $174.5 Million Raise

October 24, 1986

Combination Skin Treatments Reduce Rash From Vectibix

June 26, 2009

Virus Cancer Program Includes “Some Of The Bes Basic Research Anywhere,” Moloney Says

January 9, 1976